Patents by Inventor Yiu Lui

Yiu Lui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Docetaxel for Treating Hepatocellular Carcinoma
    Publication number: 20080045584
    Abstract: The present invention is based on the finding that docetaxel is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 ?M. It accordingly provides the use of docetaxel, or a hydrate thereof, in the manufacture of a medicament for use in the treatment of hepatocellular carcinoma.
    Type: Application
    Filed: June 12, 2007
    Publication date: February 21, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Chin-Wen CHI, Heng-Liang LIN, Tsung-Yun LIU, Wing-Yiu LUI, Gar-Yang CHAU
  • Pressure-balanced, catalyzed soot filter
    Publication number: 20060057046
    Abstract: The invention provides a catalyzed soot filter formed on a wall flow substrate having internal walls coated with catalyst compositions. The soot filter maintains a homogeneous flow of the exhaust gases through the internal walls of the substrate along the length of the filter due to the coating design. Both the efficiency and the durability of the catalytic function are increased over conventionally designed catalyzed soot filters. The catalyzed soot filter provides an integrated function for simultaneously treating the gaseous components of the exhaust (e.g., CO and HC) and the particulate matter deposited in the filter.
    Type: Application
    Filed: September 2, 2005
    Publication date: March 16, 2006
    Inventors: Alfred Punke, Torsten Mueller, Michel Deeba, Kenneth Voss, John Steger, Yiu Lui
  • Use of docetaxel for treating hepatoma
    Publication number: 20030158249
    Abstract: The present invention is based on the finding that docetaxel is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 &mgr;M. It accordingly provides the use of docetaxel, or a hydrate thereof, in the manufacture of a medicament for use in the treatment of hepatocellular carcinoma.
    Type: Application
    Filed: February 27, 2002
    Publication date: August 21, 2003
    Applicant: Aventis Pharma S.A.
    Inventors: Chin-Wen Chi, Heng-Liang Lin, Tsung-Yun Liu, Wing-Yiu Lui, Gar-Yang Chau
  • Radioactive particles and methods for preparing same
    Patent number: 6149889
    Abstract: A nuclear medical drug for localize radiotheraphy of a tumor and methods for its preparation. The drug includes a radioactive ceramic or glass particle having biocompatiblity. Ceramic or glass particles prepared by traditional processes become radioactive particles with pure .beta.-particle-emitting radionuclides after being irradiated with an appropriate flux of neutrons. The radioactive particle with suitable particle size can then be dispersed into a contrast medium for injection or can be implanted by operation.
    Type: Grant
    Filed: July 16, 1998
    Date of Patent: November 21, 2000
    Assignee: Department of Health The Executive Yuan
    Inventors: Tsung-Shune Chin, Fong-In Chou, Wing-Yiu Lui